7.6 C
New York
Saturday, December 2, 2023

Investing In Emerson Electric Co. (NYSE: EMR): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Emerson Electric Co. (EMR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.15, or 0.17%, to $88.70. The Emerson Electric Co. has recorded 88,535 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed DG Fuels Selects Emerson Engineering and Automation Portfolio to Support Sustainable Transportation Biofuels Production.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

The company is listed on the NYSE and operates within the Specialty Industrial Machinery industry segment. At the end of the last regular session, the stock closed at $88.55 and fluctuated between $89.49 as its day high and $87.51 as its day low. The current market capitalization of Emerson Electric Co. is $50.61B. A total of 3.63 million shares were traded on the day, compared to an average of 2.93M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, EMR has seen 2 BUY and 2 SELL insider trades, representing the acquisition of 7,117 and the disposition of 5,559 shares. Over the last 12 months, there were 24 BUYs and 22 SELLs from insiders. Insiders purchased 158,893 shares during that period but sold 178,447.

In the most recent transaction, McKelvey James Morgan Jr. bought 8,000 shares of EMR for 85.50 per share on Nov 09. After the transaction, the Director now owns 11,419 company shares. In a previous transaction on Nov 09, BOLTEN JOSHUA B. bought 500 shares at 85.53 per share. EMR shares that Director owns now total 26,700.

Among the insiders who bought shares, GOLDEN ARTHUR F acquired of 3,000 shares on Nov 08 at a per-share price of $85.64. This resulted in the Director holding 97,504 shares of EMR after the transaction. In another insider transaction, Ramnath Vidya sold 2,500 shares at $97.86 per share on Sep 05. Company shares held by the Senior VP & CMO now total 11,870.


The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. EMR’s most recent ex-dividend date was 11/16/2023 when it declared a $0.5250 quarterly dividend that was paid in cash on 12/11/2023. Previously, the company paid the dividend on 9/11/2023 with an ex-dividend date of 8/10/2023. The EMR stock dividend was $0.52 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for EMR in the last 3 months, the mean price target is $107.05 with high estimates of $125.00 and low estimates of $88.00. In terms of 52-week highs and lows, EMR has a high of $100.62 and a low of $76.94.

As of this writing, EMR has an earnings estimate of $1.04 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $1.09 per share and a lower estimate of $0.99. The company reported an EPS of $1.29 in the last quarter, which was 17.30% higher than expectations of $1.1.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. EMR’s latest balance sheet shows that the firm has $2.35B in Cash & Short Term Investments as of fiscal 2021. There were $6.67B in debt and $6.25B in liabilities at the time. Its Book Value Per Share was $36.17, while its Total Shareholder’s Equity was $9.92B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EMR is Buy with a score of 4.42.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles